Protocol #14-002: A Twelve-week, Double -blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study of the Safety and Efficacy of JZP-110[(R)-2-amino-3-phenylpropylcarbamate hydrochloride] in the Treatment of Excessive Sleepiness in Subjects

Project: Research project

Project Details

StatusFinished
Effective start/end date6/16/15 → 6/16/18

Funding

  • INC Research, LLC (Protocol #14-002 // Protocol #14-002)
  • Jazz Pharmaceuticals, Inc. (Protocol #14-002 // Protocol #14-002)